Public R&D Investments and Private-sector Patenting: Evidence from NIH Funding Rules

Azoulay, Pierre, Graff Zivin, Joshua S, Li, Danielle, Sampat, Bhaven N·2019·The Review of Economic Studies
DOI 10.1093/restud/rdy034

Cited by (349)

Items 101–200 of 349

  1. Information markets and nonmarkets
    Dirk Bergemann, Marco Ottaviani · 2021 · Handbook of Industrial Organization
  2. Industrial R&D and national innovation policy: an institutional reappraisal of the US national innovation system
    Ibrahim A. Shaikh, Krithika Randhawa · 2022 · Industrial and Corporate Change
  3. Innovation: Market Failures and Public Policies
    Kevin Bryan, Heidi Williams · 2021 · National Bureau of Economic Research
  4. Tackling the UK's Regional Economic Inequality: Binding Constraints and Avenues for Policy Intervention
    Anna Stansbury, Dan Turner, Ed Balls · 2023
  5. Who stands on the shoulders of Chinese (Scientific) Giants? Evidence from chemistry
    Shumin Qiu, Claudia Steinwender, Pierre Azoulay · 2024 · Research Policy
  6. Guaranteed Demand and Corporate R&D
    Sharon Belenzon Y, Larisa Cristina Cioaca · 2025 · Management Science
  7. NIH funding for patents that contribute to market exclusivity of drugs approved 2010–2019 and the public interest protections of Bayh-Dole
    Fred David Ledley, Ekaterina Galkina Cleary · 2023 · PLoS ONE
  8. Does the NIH Fund Edge Science?
    Mikko Packalén, Jay Bhattacharya · 2018 · National Bureau of Economic Research
  9. The case of the interrupting funder: dynamic effects of R&D funding and patenting in U.S. universities
    Margaret E. Blume‐Kohout · 2022 · The Journal of Technology Transfer
  10. Motivating innovation: The impact of prestigious talent funding on junior scientists
    Meiling Li, Yang Wang, Haifeng Du, Aruhan Bai · 2024 · Research Policy
  11. IP-Based Incentives Against Antimicrobial Crisis: A European Perspective
    Pedro Henrique D. Batista, Dennis Byrski, Matthias Lamping, Roberto Romandini · 2019 · GRURRR. Gewerblicher Rechtsschutz und Urheberrecht, Rechtsprechungs-Report/GRUR-DVD/GRUR-CD/IIC/Gewerblicher Rechtsschutz und Urheberrecht/Gewerblicher Rechtsschutz und Urheberrecht. Internationaler Teil
  12. Regulating Drug Prices while Increasing Innovation
    Rena M. Conti, Richard G. Frank, Jonathan Gruber A B · 2021 · New England Journal of Medicine
  13. Science and the Market for Technology
    Ashish Arora, Sharon Belenzon Y, Jungkyu Suh · 2021 · National Bureau of Economic Research
  14. Grantmaking, Grading on a Curve, and the Paradox of Relative Evaluation in Nonmarkets
    Jérôme Adda, Marco Ottaviani · 2023 · The Quarterly Journal of Economics
  15. Unexpectedness in medical research
    Yasemin Aslan, Ohid Yaqub, Bhaven N. Sampat, Daniele Rotolo · 2024 · Research Policy
  16. Can government subsidies for the digital economy promote corporate innovation?
    Xiangli Wan, Haidong Ding · 2024 · European Journal of Innovation Management
  17. Innovation and capital
    Daniel C. Fehder, Naomi Hausman, Yael V. Hochberg · 2025 · Journal of Financial Economics
  18. Judicial institution and innovation: Evidence from China's intellectual property courts reform
    Liyang Wan, Qian Wan, Zichao Yang, Ying Zhao · 2025 · Journal of Development Economics
  19. Buyers' role in innovation procurement: Evidence from US military R&D contracts
    Francesco Decarolis, Gaétan de Rassenfosse, Leonardo Maria Giuffrida, Elisabetta Iossa, Vincenzo Mollisi, Emilio Raiteri, Giancarlo Spagnolo · 2021 · Journal of Economics & Management Strategy
  20. Systematic analysis of the scientific-technological production on the use of the UV, H2O2, and/or Cl2 systems in the elimination of bacteria and associated antibiotic resistance genes
    Paula Andrea Espinosa-Barrera, Marcela Gómez-Gómez, Javier Vanegas, Fiderman Machuca‐Martínez, Ricardo Antonio Torres-Palma, Diana Martínez‐Pachón, Alejandro Moncayo‐Lasso · 2024 · Environmental Science and Pollution Research
  21. Public Risk-Taking and Rewards During the COVID-19 Pandemic - A Case Study of Remdesivir in the Context of Global Health Equity
    Sabrina Wimmer, Sarai Keestra · 2020 · International Journal of Health Policy and Management
  22. European union's regions between cohesion and sustainability
    Romeo‐Victor Ionescu, Monica Laura Zlati, Valentin Marian Antohi · 2021 · Technological Forecasting and Social Change
  23. Does Peer Review Penalize Scientific Risk Taking? Evidence from NIH Grant Renewals
    Pierre Azoulay, Wesley H. Greenblatt · 2025 · National Bureau of Economic Research
  24. Talent, basic research and growth
    Carmen Marchiori, Enrico Minelli · 2023 · Journal of Economic Theory
  25. Political, economic and research disintegration: The impact of geopolitical uncertainty on innovation and cross-border R&D collaborations
    Enrico Vanino, Mustapha Douch, İsmail Çakmak · 2026 · Research Policy
  26. Private and Public Investments in Biomedical Research
    Maya Durvasula, Lisa Larrimore Ouellette, Heidi Williams · 2021 · AEA Papers and Proceedings
  27. Market Size and Research: Evidence from the Pharmaceutical Industry
    Dennis Byrski, Fabian Gaessler, Matthew John Higgins · 2021 · National Bureau of Economic Research
  28. Who Stands on the Shoulders of Chinese (Scientific) Giants? Evidence from Chemistry
    Shumin Qiu, Claudia Steinwender, Pierre Azoulay · 2022 · National Bureau of Economic Research
  29. Across disciplines, to make an impact. The technological impact of boundary-spanning research projects
    Federico Munari, Hérica Morais Righi, Laura Toschi · 2025 · Technovation
  30. A new approach to measuring invention commercialization: An application to the SBIR program
    Carlo Bottai, Gaétan de Rassenfosse, Emilio Raiteri · 2025 · Research Policy
  31. The Returns to Government R&D: Evidence from U.S. Appropriations Shocks
    Andrew J. Fieldhouse, Karel Mertens, Federal Reserve Bank of Dallas · 2023 · Federal Reserve Bank of Dallas, Working Papers
  32. From Public Labs to Private Firms: Magnitude And Channels of Local R&D Spillovers
    Antonin Bergeaud, Arthur Guillouzouic, Emeric Henry, Clément Malgouyres · 2025 · The Quarterly Journal of Economics
  33. Evaluation and Learning in R&D Investment
    Alexander P. Frankel, Joshua Krieger, Danielle Li, Dimitris Papanikolaou · 2023 · National Bureau of Economic Research
  34. Publish or perish: Up-or-out rules and research performance of universities
    Bingyan Yang, Rui-Ming Liu, Chuanbin Liu, Yang Shi · 2024 · China Economic Review
  35. Government subsidies, digital transformation, and innovation dynamics
    Wenyue Cui, Jie Tang, Lu Yang · 2025 · Economics of Innovation and New Technology
  36. Regional R&D spending, absorptive capacity and the regional innovation paradox
    Huanjia Ma, Raquel Ortega‐Argilés, Matthew Lyons, Kurt Kratena · 2026 · Spatial Economic Analysis
  37. The paradox of government-funded innovation in weakly institutionalized environments
    Natalia Lamberova · 2024 · Journal of Innovation & Knowledge
  38. The impact of startup subsidies on survival, growth, and stakeholder value
    Yolanda Fuertes Callén, Beatriz Cuéllar Fernández, Adriana Serrano‐Magdalena · 2024 · Journal of Small Business Management
  39. Discovery and Development of Pregabalin (Lyrica)
    Rachel Elizabeth Barenie, Jonathan J. Darrow, Jerry Avorn, Aaron Seth Kesselheim · 2021 · Neurology
  40. The Government and Pharmaceutical Innovation: Looking Back and Looking Ahead
    Bhaven N. Sampat · 2021 · The Journal of Law Medicine & Ethics
  41. Research Subsidy Spillovers, Two Ways
    Kyle Roy Myers, Lauren Lanahan · 2020 · SSRN Electronic Journal
  42. Beyond Feasibility Filters: How Expertise Heterogeneity Enables Innovation Recognition
    Jacqueline N. Lane, Zoe Szajnfarber, Jason C. Crusan, Michael Menietti · 2022 · SSRN Electronic Journal
  43. Distorted Innovation: Does the Market Get the Direction of Technology Right?
    Daron Acemoğlu · 2023 · SSRN Electronic Journal
  44. Considering Returns on Federal Investment in the Negotiated “Maximum Fair Price” of Drugs Under the Inflation Reduction Act: an Analysis
    Edward Zhou, Paula G. Chaves da Silva, Debbie Quijada, Fred David Ledley · 2024
  45. The rise of large language models and the direction and impact of US federal research funding
    Qian, Yifan, Wen, Zhe, Furnas, Alexander C., Bai, Yue, Shao, Erzhuo, Wang, Dashun · 2026 · Proceedings of the National Academy of Sciences
  46. Kindleberger Cycles: Method in the Madness of Crowds?
    Randall Mørck · 2022 · Annual Review of Financial Economics
  47. Quantifying public and private investment in European biopharmaceutical research and development
    Annabelle C. Fowler, Kathleen Grieve, Andreas Maos, Tim Wilsdon · 2024 · Health Affairs Scholar
  48. Research-targeting, spillovers, and the direction of science: Evidence from HIV research-funding
    Ohid Yaqub, Josie Coburn, Duncan A.Q. Moore · 2024 · Research Policy
  49. The determinants and impact of research grants: The case of Brazilian productivity scholarships
    Marcelo Perlin, Denis Borenstein, Takeyoshi Imasato, Marcos Henrique Reichert · 2024 · Journal of Informetrics
  50. Can International Patent Law Help Mitigate Cancer Inequity in LMICs?
    Srividya Ragavan, Amaka Vanni · 2020 · The AMA Journal of Ethic
  51. The perils of working with big data, and a SMALL checklist you can use to recognize them
    Scott A. Brave, R. Andrew Butters, Michael S. Fogarty · 2021 · Business Horizons
  52. Identification of high- and new-technology enterprises, supplier relationship and technological innovation: Evidence from China
    Lingling Xu, Huijie Zhong · 2024 · International Review of Economics & Finance
  53. R&D Spillovers for Public R&D Productivity
    Hye Yeon Kwon, Illoong Kwon · 2019 · Global Economic Review
  54. The private versus public contribution to the biomedical literature during the COVID-19, Ebola, H1N1, and Zika public health emergencies
    Reed F. Beall, Javad Moradpour, Aidan Hollis · 2021 · PLoS ONE
  55. What Can Economics Say About Alzheimer's Disease?
    Amitabh Chandra, Courtney Coile, Corina Mommaerts · 2020 · National Bureau of Economic Research
  56. The New Empirics of Industrial Policy
    Nathaniel Lane · 2021
  57. Causal Inference During a Pandemic: Evidence on the Effectiveness of Nebulized Ibuprofen as an Unproven Treatment for COVID-19 in Argentina
    Sebastián Calónico, Rafael Di Tella, Juan Cruz Lopez Del Valle · 2022 · National Bureau of Economic Research
  58. The NBER Orange Book Dataset: A User’s Guide
    Maya Durvasula, C. Scott Hemphill, Lisa Larrimore Ouellette, Bhaven N. Sampat, Heidi Williams · 2022 · National Bureau of Economic Research
  59. Introduction to structural causal models in science studies
    Thomas Klebel, Vincent Traag · 2025 · Quantitative Science Studies
  60. More money, more digital? The impact of state grants on digital transformation in small and medium-sized enterprises
    Jasmin Demann, Claudia Doblinger, Sangeeta Nar · 2026 · The Journal of Strategic Information Systems
  61. Analysis of Public Technology Collaborative Innovation Based on Private Technology: A Tripartite Evolutionary Game Approach
    Yunjuan Liang, Liang Xin, Hua Wei · 2023 · Complexity
  62. Corporate misconduct and innovation: Evidence from the pharmaceutical industry
    Omer Unsal, William J. Hippler · 2024 · Research in International Business and Finance
  63. Teamwork Coaching in the Research Development Process
    Bryan Stephens, Joanna B. Downer, Jonathon N. Cummings · 2024 · Small Group Research
  64. Public research institutes in Brazil: evidence of research and innovation impact
    Concepta Margaret Mcmanus, Abilio Afonso Baeta Neves, Jorge Luis Nicolas Audy, Álvaro Toubes Prata · 2024 · Innovation The European Journal of Social Science Research
  65. Public sector replacement of privately funded pharmaceutical R&D: cost and efficiency considerations
    David G. Proudman, Urvi S. Desai, Dumingu Aparna Gomes, Maks Khomenko, Silas Martin, Dave Nellesen, Ulrich Neumann, Henry G. Grabowski · 2024 · Journal of Medical Economics
  66. Medical research and health care finance: Evidence from Academic Medical Centers
    Pierre Azoulay, Misty L. Heggeness, Jennifer L. Kao · 2024 · Research Policy
  67. Is the supermultiplier currently nil? - A replication study of Deleidi and Mazzucato (2021)
    Jens Boysen‐Hogrefe · 2025 · Research Policy
  68. Indução de endividamento hospitalar na compra de medicamento em situação de monopólio: o caso do mesilato de imatinibe
    Carolinne Thays Scopel, Gabriela Costa Chaves · 2015 · Cadernos de Saúde Pública
  69. Political favoritism towards resource allocation: Evidence of grants by natural science foundation in China
    Zihua Liu, Sili Zhou · 2021 · Emerging Markets Review
  70. The Entrepreneurial State and Public Options
    Mariana Mazzucato, Henry Lishi Li · 2021 · Cambridge University Press eBooks
  71. Can Grants to Consortia Spur Innovation and Science-Industry Collaboration? Regression-Discontinuity Evidence from Poland
    David John McKenzie, Miriam Bruhn · 2017 · World Bank, Washington, DC eBooks
  72. INNOVATION AND CAPITAL
    Naomi Hausman, Daniel C. Fehder, Yael V. Hochberg · 2020 · SSRN Electronic Journal
  73. Indirect Cost Recovery in U.S. Innovation Policy: History, Evidence, and Avenues for Reform
    Pierre Azoulay, Daniel Groß, Bhaven N. Sampat · 2025 · National Bureau of Economic Research
  74. The public origins of American innovation
    A. Gazzani, Joseba Martinez, Filippo Natoli, Paolo Surico · 2026 · Social Science Research Network
  75. Does Getting Forecasts Earlier Matter? Evidence from Winter Advisories and Vehicle Crashes
    Vaibhav Anand · 2025 · American Economic Journal Economic Policy
  76. The role of social ties in spreading innovation: Evidence from alien merchant guilds in China
    Xiaoquan Wang, Qi Wu, Hong Zhang · 2025 · Journal of Economic Behavior & Organization
  77. Does innovation policy promote innovation? Evidence from innovation targets in China's five-year plans
    Xianbin Wang, Xitian Zheng, Dan Cao · 2025 · Economic Modelling
  78. Are Complementary Policies Substitutes? Evidence from R&D Subsidies in the United Kingdom
    Jacquelyn Pless · 2026 · American Economic Journal Economic Policy
  79. How Geopolitics Is Changing the Economics of Innovation
    Aaron Chatterji, Fiona Murray · 2026 · Entrepreneurship and Innovation Policy and the Economy
  80. Spatial–Temporal Pattern Evolution and Differentiation Mechanism of Urban Dual Innovation: A Case Study of China’s Three Major Urban Agglomerations
    Qingyi Chen, Yuting Liu, Zuolin Yao · 2024 · Land
  81. The Government Patent Register: A new resource for measuring U.S. government-funded patenting
    Daniel P. Gross, Bhaven N. Sampat · 2024 · Research Policy
  82. Assessing the scientific and economic impacts of the experiments conducted onboard the International Space Station
    Max Wang, Ken Savin · 2025 · npj Microgravity
  83. Regression discontinuity design and its applications to Science of Science: A survey
    Meiling Li, Yang Zhang, Yang Wang · 2023 · Journal of Data and Information Science
  84. What Drives Innovation? Lessons from COVID-19 R&D
    Ruchir Agarwal, Patrick Gaulé · 2021 · IMF Working Paper
  85. Does Cheap Access Encourage Science? Evidence from the WWII Book Replication Program
    Barbara Biasi, Petra Moser · 2014 · SSRN Electronic Journal
  86. Research Subsidy Spillovers, Two Ways
    Kyle Roy Myers, Lauren Lanahan · 2021 · Academy of Management Proceedings
  87. Valuing Pharmaceutical Drug Innovations
    Gaurab Aryal, Federico Ciliberto A, Leland E. Farmer, Ekaterina A. Khmelnitskaya · 2023 · SSRN Electronic Journal
  88. The Private Value of Innovating for the Government
    Ashish Arora, Sharon Belenzon Y, Larisa Cristina Cioaca, Elia Ferracuti · 2025 · National Bureau of Economic Research
  89. Natural Language Processing and Innovation Research
    Antonin Bergeaud, Adam B. Jaffe, Dimitris Papanikolaou · 2025 · National Bureau of Economic Research
  90. Estimating the Economic and Budgetary Effects of Research Investments
    Theresa Gullo, Benjamin Page, David Weiner, Heidi Williams · 2025 · Tax Policy and the Economy
  91. Video game engines as the new “virtual” Skinner box
    Michael E. Young, Patrick M. Hancock, Lucas Watson, Brian C. Howatt, Robert Southern, Karissa B. Payne · 2026 · Journal of the Experimental Analysis of Behavior
  92. The Social Returns to Public R&D
    Andrew J. Fieldhouse, Karel Mertens · 2026 · Entrepreneurship and Innovation Policy and the Economy
  93. Green finance policy and climate adaptation innovation: evidence from China
    Jingru Ma, Yewei Wu, Wenxin Liu · 2026 · International Journal of Managerial Finance
  94. Impact of the funding structure on R&D in cases of European Union and Russian Federation
    Геннадий Евгеньевич Алпатов, Kirill Gusarov, Elena M. Korostyshevskaya · 2021 · SHS Web of Conferences
  95. Productivity spillovers in endogenous coauthor networks
    Wei Cheng · 2022 · Empirical Economics
  96. Scientific rewards for biomedical specialization are large and persistent
    Gaétan de Rassenfosse, Kyle Higham, Orion Penner · 2022 · BMC Biology
  97. R&D grants and medical innovation
    Omer Unsal, Reza Houston · 2023 · Journal of Economics and Business
  98. Advancing Small Business Inclusion in Public Procurement: Evidence From U.S. Federal Government R&D Contracts
    Dwaipayan Roy, Anant Mishra, Kingshuk Kanti Sinha · 2024 · Production and Operations Management
  99. Indirect effects of R&D subsidies: labor mobility as a channel for knowledge spillovers
    Abdulaziz Abrar Reshid, Erik Hegelund, Peter J. Svensson · 2025 · Small Business Economics
  100. Industrial agglomeration, university-enterprise cooperation and enterprise innovation
    Chaojing Li, Qiming Li · 2025 · Innovation